GX-188E
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for GX-188E, covering 2014-02-17 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer [Phase 2]